scPharmaceuticals (SCPH) Stock Analysis
NASDAQHealthcareBiotechnology
Track SCPH in your portfolio for free · Portfolio tracker
What scPharmaceuticals does
scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the advancement of a single-use SmartDose device. Founded in 2013, the company's main operations are based in Burlington, Massachusetts.
Key metrics
ETFs linked to SCPH
Broad-market and Healthcare sector ETFs an investor holding scPharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how SCPH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze SCPH in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for scPharmaceuticals?
- scPharmaceuticals trades under the ticker SCPH on NASDAQ.
- Which exchange is SCPH listed on?
- SCPH is listed on NASDAQ.
- What sector does scPharmaceuticals operate in?
- scPharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze SCPH in a portfolio?
- PortView shows SCPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.